ICER’s Leqembi Assessment Inches Higher, Still Sees Eisai Price As Too High

Net Cost Of Alzheimer’s Drug May Still Be Within Range

 
• By Mandy Jackson
  
Cog Gear Wheel with arrows on the technology abstract background
Leqembi's final cost may still fall within ICER's recommended range • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip